Abstract

BackgroundDisabled-2 (Dab2) is known as a tumor suppressor as well as a Wnt pathway inhibitor. We previously reported that Dab2 was down-regulated due to gene promoter hypermethylation in lung cancer. Here, we aim to study if X-ray irradiation can induce de-methylation of the Dab2 gene and subsequently up-regulate its expression, and also to attempt to suppress the malignant biological behavior of and enhance the radiosensitivity in lung cancer cells with hypermethylation of the Dab2 gene.MethodsImmunostaining was performed to investigate the relationship between Dab2 expression and lung cancer clinicopathological characteristics. Bisulfite sequencing PCR (BSP) was used to evaluate the methylation status of lung cancer cells with or without X-ray treatment. Real-time PCR and western Blot were performed to investigate the expression of Dab2, Wnt pathway factors, DNMTs and methyl CpG binding protein 2 (MeCP2). Colony Formation, matrigel invasion and xenograft experiment were performed to evaluate the malignant biological behavior of lung cancer cells with irradiation.ResultsThe result of immunostaining of Dab2 in lung cancer tissues showed that decreased Dab2 expression was positively correlated with poor differentiation, lymph node metastasis, advanced TNM stage and poor prognosis. X-ray treatment significantly up-regulated Dab2 expression and inhibited Wnt factors in LK2 cells (with hypermethylation of the Dab2 gene promoter, P < 0.05), but not in SPC-A-1 cells (with hypomethylation of the Dab2 gene promoter); however, the effect could be reversed by Dab2 or Axin knockdown (P < 0.05). Decreased expression of DNMT1, DNMT3b and MeCP2 could be detected in both LK2 and SPC-A-1 cells compared to non-irradiated cells (P < 0.05). Both in vitro studies and in vivo xenograft tumor growth demonstrated that X-ray could significantly inhibit the proliferation and invasion of LK2 but not SPC-A-1 cells (P < 0.05).ConclusionIn general, X-ray-induced up-regulation of Dab2 and inhibition of the Wnt pathway may be mediated by de-methylation of a hypermethylated Dab2 gene promoter. X-ray treatment significantly inhibits proliferation and invasion of lung cancer cells with hypermethylation of the Dab2 gene promoter, but is less effective in lung cancer cells with hypomethylation of the Dab2 gene promoter. These results indicate that the methylation status of the Dab2 gene promoter might be a potential predictor of the radiosensitivity of lung cancer cells.

Highlights

  • Disabled-2 (Dab2) is known as a tumor suppressor as well as a Wnt pathway inhibitor

  • Low Dab2 expression in lung cancer correlates with differentiation, TNM stage, lymph node metastasis and poor outcome Immunohistochemical staining for Dab2 revealed low expression in 97 cases and high expression in 40 cases

  • Effect of X-ray irradiation on Dab2 mRNA and methylation level in lung cancer cells A 353 bp sequence was assessed for average methylation frequency (AMF) in this study

Read more

Summary

Introduction

Disabled-2 (Dab2) is known as a tumor suppressor as well as a Wnt pathway inhibitor. We previously reported that Dab was down-regulated due to gene promoter hypermethylation in lung cancer. Abnormal Wnt/Wingless signaling pathway activation has been reported in many cancers and is supposed to promote proliferation, invasion, and metastasis [1, 2]. We previously reported that the Wnt signaling pathway is abnormally activated in lung cancer due to decreased expression of Dab and Axin, which inhibits the degradation of β-catenin resulting in its accumulation in the cytoplasm and nucleus. This accumulation of β-catenin activates the target genes of the Wnt pathway, such as cyclin D1, MMP-7 and c-myc. We have previously found that hypermethylation of the Dab gene promoter was correlated with reduced expression in lung cancer [17,18,19]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call